Goodwin Publishes Biosimilars Patent Litigation Update, Biosimilars Investment Guidelines

Biosimilar News  •  BPCIA and Related U.S. Statutes  •  Goodwin  •  Market Analyses  •  Regulatory Guidances

Goodwin announced today the release of its 2016 BPCIA Litigation Update and Thinking of Investing In a Biosimilars Product? The 2016 BPCIA Litigation Update recaps a busy year in the legal world of biosimilars, offering background, legal analysis and the status of the year’s most pivotal cases. Thinking of Investing In a Biosimilars Product? outlines key considerations for investors interested in the space.  For more information about both publications and to download your copies, please click here.

Download PDF

Comments are closed.